• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

6,369
2,299
1,858
1,846
1,725

COUNTRY

866
647
270
253
211

CATEGORIES

  • 858
  • 186
  • 678
  • 1,126
  • 391
  • 270
  • 251
  • 65
  • 378
  • 687
  • 1,329
  • 1,355
  • 625
  • 884
  • 1,695
  • 2,675
  • 507
  • 732
  • 0
  • 93

PRICE

6,805
11,438
17,948
25,135

PUBLISHED

1,976
2,671
7,331
25,135

PRODUCT TYPE

21,012
2,901
871
164
75
44
21
21
19
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H1, 2014

Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Prostatic Intraepithelial Neoplasia Global Clinical Trials Review, H1, 2014" provides...

April 2014
FROM

Retinoblastoma Global Clinical Trials Review, H1, 2014

Retinoblastoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Retinoblastoma Global Clinical Trials Review, H1, 2014" provides data on the Retinoblastoma clinical trial...

April 2014
FROM

Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014

Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Squamous Non-Small Cell Lung Carcinoma Global Clinical Trials Review, H1, 2014" provides...

April 2014
FROM

Urinary Tract Cancer Global Clinical Trials Review, H1, 2014

Urinary Tract Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Urinary Tract Cancer Global Clinical Trials Review, H1, 2014" provides data on the Urinary Tract Cancer...

April 2014
FROM

Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014

Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014" provides data on the...

April 2014
FROM

EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023

EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023 Summary Atrial fibrillation (AF) is a disorder of the heart's electrical system AF is one of the most common cardiovascular diseases...

April 2014
FROM

EpiCast Report: Gout - Epidemiology Forecast to 2023

EpiCast Report: Gout - Epidemiology Forecast to 2023 Summary Gout is a type of inflammatory arthritis The disease is triggered by the crystallization of uric acid within the joints and is associated...

April 2014
FROM

Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014

Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Recurrent Head And Neck Cancer Squamous Cell Carcinoma Global Clinical...

April 2014
FROM

Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014

Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Relapsed Acute Myeloid Leukemia Global Clinical Trials Review, H1, 2014" provides data on...

April 2014
FROM

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Small-Cell Lung...

April 2014
FROM

Vulvar Cancer Global Clinical Trials Review, H1, 2014

Vulvar Cancer Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Vulvar Cancer Global Clinical Trials Review, H1, 2014" provides data on the Vulvar Cancer clinical trial scenario....

April 2014
FROM

Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2014

Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2014 Summary Our clinical trial report, “Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H1, 2014" provides...

April 2014
FROM

South Africa Pharmaceuticals and Healthcare Report Q2 2014

BMI View: South Africa is the best investment opportunity for multinational drugmakers seeking to enter the African market - boasting the largest medicines market on the continent and poised for high...

April 2014

Greece Pharmaceuticals and Healthcare Report Q2 2014

BMI View: Despite the Greek economy's expected return to growth in 2014, we expect no lessening in the pressures on the Greek pharmaceutical and healthcare sectors over the medium- to long term. Further...

April 2014

US Companion Diagnostics Market Trends and Insights

A complete companion diagnostic market analysis must include both developers of targeted drugs and developers of companion diagnostic tests This research deliverable discusses important trends in the...

April 2014
FROM
Intercept Pharmaceuticals' Obeticholic Acid - Clinical/regulatory update Intercept Pharmaceuticals' Obeticholic Acid - Clinical/regulatory update - Product Thumbnail Image

Intercept Pharmaceuticals' Obeticholic Acid - Clinical/regulatory update

Obeticholic acid (OCA) is a derivative of chenodeoxycholic acid, the dominant component of bile It is a potent stimulator of farnesoid X receptor and in that way differs both from chenodeoxycholic acid...

April 2014
FROM

Pharmacy Retail Market in India 2014

'Pharmacy Retail Market in India 2014' elaborates the changing role of pharmacy outlets and the gradual transition of the industry as a whole towards an organized format. At present, pharmacy retail...

April 2014
FROM

Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others)

Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments The global market for human vaccines experienced strong growth through 2013 with the introduction of new vaccines...

April 2014
FROM

A Strategic Analysis of the Global Anti-obesity Prescription Pharmaceuticals Market

Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval...

April 2014
FROM

Hematology in Traditional Chinese Medicine Cardiology

Hematology in Traditional Chinese Medicine Cardiology instructs readers on the blood, complement and immune system from the western and Chinese medicine perspectives. The book focuses on the cardiovascular...

April 2014
Loading Indicator

Our Clients

Our clients' logos